Longboard Pharmaceuticals Statistics
Total Valuation
LBPH has a market cap or net worth of $807.35 million. The enterprise value is $490.29 million.
| Market Cap | 807.35M |
| Enterprise Value | 490.29M |
Important Dates
The last earnings date was Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LBPH has 38.89 million shares outstanding. The number of shares has increased by 73.06% in one year.
| Shares Outstanding | 38.89M |
| Shares Change (YoY) | +73.06% |
| Shares Change (QoQ) | +47.14% |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 123.45% |
| Float | 20.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.57 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 31.43, with a Debt / Equity ratio of 0.01.
| Current Ratio | 31.43 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.90% and return on invested capital (ROIC) is -19.80%.
| Return on Equity (ROE) | -49.90% |
| Return on Assets (ROA) | -46.00% |
| Return on Capital (ROIC) | -19.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.16M |
| Employee Count | 50 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +120.11% in the last 52 weeks. The beta is 1.27, so LBPH's price volatility has been higher than the market average.
| Beta (1Y) | 1.27 |
| 52-Week Price Change | +120.11% |
| 50-Day Moving Average | 19.90 |
| 200-Day Moving Average | 12.95 |
| Relative Strength Index (RSI) | 51.26 |
| Average Volume (30 Days) | 428,427 |
Short Selling Information
The latest short interest is 4.33 million, so 11.15% of the outstanding shares have been sold short.
| Short Interest | 4.33M |
| Short Previous Month | 4.92M |
| Short % of Shares Out | 11.15% |
| Short % of Float | 20.81% |
| Short Ratio (days to cover) | 11.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -62.92M |
| Pretax Income | -57.95M |
| Net Income | -57.95M |
| EBITDA | -57.95M |
| EBIT | -57.95M |
| Earnings Per Share (EPS) | -$2.24 |
Balance Sheet
The company has $321.04 million in cash and $3.98 million in debt, giving a net cash position of $317.06 million or $8.15 per share.
| Cash & Cash Equivalents | 321.04M |
| Total Debt | 3.98M |
| Net Cash | 317.06M |
| Net Cash Per Share | $8.15 |
| Equity / Book Value | 313.71M |
| Book Value Per Share | 8.07 |
| Working Capital | 313.15M |
Cash Flow
| Operating Cash Flow | -52.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | -52.95M |
| FCF Per Share | -$1.50 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LBPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -73.06% |
| Shareholder Yield | -73.06% |
| Earnings Yield | -7.18% |
| FCF Yield | -6.56% |
Analyst Forecast
The average price target for LBPH is $39.71, which is 91.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $39.71 |
| Price Target Difference | 91.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -2.01% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |